All lobbying filings

Hance Scarborough

Hance Scarborough filed a Q2 report for Boehringer Ingelheim USA Corporation on July 17, 2026, reporting $20,000 in lobbying income.

Lobbying for Boehringer Ingelheim USA Corporation · Pharmaceutical Company

As filed: HANCE SCARBOROUGH for BOEHRINGER INGELHEIM USA CORPORATION.

All filings by Hance Scarborough · Everything Boehringer Ingelheim USA Corporation has reported

Filing · LD-2 quarterly report Q2 report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 17, 2026

Income

$20,000

What the client paid this registrant for the period.

Client based in

Connecticut

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Agriculture

National Animal Disease Preparedness and Response Program, and the National Animal Vaccine and Veterinary Countermeasures Vaccine Bank. Farm Bill

Animals

Provide ongoing animal health policy monitoring, assessment, and research support. Telemedicine/telehealth legislation. Farm Bill. USDA Texas New World screw worm facility and eradication.

Pharmacy

Provide ongoing animal health policy monitoring, assessment, and research support. Telemedicine/telehealth legislation. Farm Bill

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.